Healthcare provider profile · identity verified

Lea Reyes, MD

Internal Medicine · BETHLEHEM, PA · NPI 1184816498

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	823	214
Amlodipine Besylate	Amlodipine Besylate	460	127
Levothyroxine Sodium	Levothyroxine Sodium	449	120
Losartan Potassium	Losartan Potassium	372	93
Lisinopril	Lisinopril	360	102
Omeprazole	Omeprazole	292	91
Gabapentin	Gabapentin	219	68
Metoprolol Succinate	Metoprolol Succinate	212	55
Rosuvastatin Calcium	Rosuvastatin Calcium	197	56
Hydrochlorothiazide	Hydrochlorothiazide	166	48
Pantoprazole Sodium	Pantoprazole Sodium	152	43
Simvastatin	Simvastatin	138	38
Furosemide	Furosemide	137	37
Metformin Hcl	Metformin Hcl	131	37
Alprazolam	Alprazolam	130	39
Pravastatin Sodium	Pravastatin Sodium	128	36
Metoprolol Tartrate	Metoprolol Tartrate	118	33
Fluticasone Propionate	Fluticasone Propionate	114	47
Escitalopram Oxalate	Escitalopram Oxalate	111	31
Lorazepam	Lorazepam	111	23
Eliquis	Apixaban	105	23
Famotidine	Famotidine	103	32
Metformin Hcl Er	Metformin Hcl	102	30
Sertraline Hcl	Sertraline Hcl	102	30
Albuterol Sulfate Hfa	Albuterol Sulfate	101	41
Trazodone Hcl	Trazodone Hcl	95	30
Carvedilol	Carvedilol	85	24
Atenolol	Atenolol	76	21
Citalopram Hbr	Citalopram Hydrobromide	75	17
Montelukast Sodium	Montelukast Sodium	70	18
Allopurinol	Allopurinol	68	19
Ozempic	Semaglutide	67	13
Tamsulosin Hcl	Tamsulosin Hcl	64	18
Tramadol Hcl	Tramadol Hcl	64	19
Buspirone Hcl	Buspirone Hcl	61	14
Duloxetine Hcl	Duloxetine Hcl	60	14
Venlafaxine Hcl Er	Venlafaxine Hcl	60	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Potassium Chloride	Potassium Chloride	57	17
Bupropion Xl	Bupropion Hcl	55	17
Oxycodone Hcl	Oxycodone Hcl	48	14
Xarelto	Rivaroxaban	47	11
Cephalexin	Cephalexin	46	34
Alendronate Sodium	Alendronate Sodium	45	14
Januvia	Sitagliptin Phosphate	44	suppressed
Ezetimibe	Ezetimibe	43	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	suppressed
Spironolactone	Spironolactone	42	suppressed
Benazepril Hcl	Benazepril Hcl	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Jardiance	Empagliflozin	41	12
Clonazepam	Clonazepam	40	13
Zolpidem Tartrate	Zolpidem Tartrate	40	14
Synthroid	Levothyroxine Sodium	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	36
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	11
Pregabalin	Pregabalin	32	suppressed
Prednisone	Prednisone	30	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Klor-Con M20	Potassium Chloride	29	11
Methocarbamol	Methocarbamol	28	11
Prochlorperazine Maleate	Prochlorperazine Maleate	28	suppressed
Valsartan	Valsartan	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	11
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Linzess	Linaclotide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Valacyclovir	Valacyclovir Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Ketoconazole	Ketoconazole	24	14
Warfarin Sodium	Warfarin Sodium	24	suppressed
Finasteride	Finasteride	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Temazepam	Temazepam	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Ibuprofen	Ibuprofen	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Lactulose	Lactulose	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Tizanidine Hcl	Tizanidine Hcl	19	11
Topiramate	Topiramate	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Azithromycin	Azithromycin	16	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ramipril	Ramipril	12	suppressed
Torsemide	Torsemide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error